Osaic Holdings
BCAX

Osaic Holdings’s Bicara Therapeutics BCAX Stock Holding History

Osaic Holdings’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.3K Sell
4,489
-5
-0.1% -$86 ﹤0.01% 4767
2025
Q4 		$75.6K Buy
4,494
+87
+2% +$1.49K ﹤0.01% 4949
2025
Q3 		$69.6K Buy
4,407
+3,974
+918% +$44.5K ﹤0.01% 5085
2025
Q2 		$4.02K Buy
+433
New +$5.16K ﹤0.01% 6660
2025
Q1 		– Sell
-255
Closed -$4.44K – 7764
2024
Q4 		$4.44K Buy
255
+218
+589% +$4.54K ﹤0.01% 6261
2024
Q3 		$942 Buy
+37
New +$944 ﹤0.01% 6857

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Osaic Holdings's BCAX Position: Q1 2026 in Review

Osaic Holdings reduced its Bicara Therapeutics (BCAX) stake by 0.11% in Q1 2026, selling an estimated $86 and leaving 4,489 shares worth $89.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4767.

Osaic Holdings first reported a position in BCAX in Q3 2024 and has held it in 6 quarters since. 146 funds tracked by Wall St. Rank hold BCAX as of Q1 2026.

  • Osaic Holdings held 4,489 shares of Bicara Therapeutics worth $89.3K as of Q1 2026.
  • Osaic Holdings sold 5 Bicara Therapeutics shares in Q1 2026, an estimated $86.
  • Bicara Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4767 holding.
  • Osaic Holdings first reported a position in Bicara Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 146 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.